Published • loading... • Updated
US court blocks mail-order access to abortion drugs, for now
The ruling restores an in-person dispensing requirement and could force patients in every state to travel for medication abortion care, advocates said.
- On Friday, May 1, 2026, the 5th U.S. Circuit Court of Appeals issued a temporary stay blocking the Food and Drug Administration's 2023 policy permitting mail-order mifepristone, reinstating nationwide in-person dispensing requirements while Louisiana's legal challenge proceeds.
- Louisiana Attorney General Liz Murrill sued the FDA, arguing the 2023 rule undermined state abortion bans and caused the state $92,000 in Medicaid costs for emergency care from out-of-state mifepristone complications.
- Circuit Judge Stuart Kyle Duncan wrote that the policy "facilitates nearly 1,000 illegal abortions in Louisiana per month," while the panel ruled federal regulations created an end-run around the state's prohibition where medication now accounts for two-thirds of U.S. abortions.
- Julia Kaye, an American Civil Liberties Union lawyer, warned the ruling will "affect patients' access to abortion and miscarriage care in every state," while Susan B. Anthony Pro-Life America celebrated it as a "huge victory" against the "mail-order abortion drug regime."
- Legal experts anticipate a likely appeal to the Supreme Court, while providers prepare contingency plans including efforts to offer alternative misoprostol-only regimens to patients who can no longer access mifepristone via telehealth.
Insights by Ground AI
Podcasts & Opinions
386 Articles
386 Articles
Conservative Louisiana stopped sending abortion drugs, the Supreme Court responded promptly, and the case could split the whole country.
Abortion clash heats up at a politically fraught moment
Since the overturning of Roe v. Wade four years ago, abortions in the United States have actually increased, with the rise of abortion medication sent through the mail. Now, a nationwide ruling put the issue back before the Supreme Court – and on the campaign trail.
·Boston, United States
Read Full ArticleCoverage Details
Total News Sources386
Leaning Left95Leaning Right61Center141Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 32%
C 47%
R 21%
Factuality
To view factuality data please Upgrade to Premium
